Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Beam Therapeutics Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 23.21 · gapped above the open, never looked back. High/low 23.37 at 4:00 am ET, 23.33 at 5:00 am ET.
275 institutional managers report a position in Beam Therapeutics Inc. worth $3.8B between them, filed on form 13F for the quarter ending 2026-06-30. 20 of them hold 80% of it, the largest being FMR LLC at 11.44%.
250 more managers in the register
20 managers hold 80% of the $3.8B institutional base. The other 255 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +2 more · 9.29% of BEAM, 15.50% of PACB
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +2 more · 9.29% of BEAM, 11.60% of ARCT
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +4 more · 9.29% of BEAM, 7.77% of PRME
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +1 more · 9.29% of BEAM, 13.31% of QSI
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +1 more · 9.29% of BEAM, 15.32% of BLSH
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +4 more · 9.29% of BEAM, 11.40% of NTLA
Managers holding a meaningful stake in BEAM also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
BEAM (Beam Therapeutics Inc.) has 5 disclosed suppliers and 6 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: PRME +1.59%, in healthcare.